Back
Direxion Daily Healthcare Bull 3X ETF Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
2
CURE
Direxion Daily Healthcare Bull 3X ETF
Last Price:
101.70
Seasonality Move:
10.92%
Sell
20
ALNY
Alnylam Pharmaceuticals
Last Price:
235.53
Seasonality Move:
10.85%
Sell
2
Direxion Daily Healthcare Bull 3X ETF (CURE)
is a Sell
Is Direxion Daily Healthcare Bull 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily Healthcare Bull 3X ETF [CURE] share price is $101.78. The Score for CURE is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- CURE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $235.56. The Score for ALNY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CURE Stock Price Chart
What is Direxion Daily Healthcare Bull 3X ETF's stock price today?
-
The Direxion Daily Healthcare Bull 3X ETF share price today is $101.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CURE is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $235.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
CURE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.76 | Sell |
| Relative Strength Index (14 RSI): | 24.73 | Sell |
| Chaikin Money Flow: | -81439 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (112.4 - 126.88) | Sell |
| Bollinger Bands (100): | (117.48 - 135) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.97 | Sell |
| Relative Strength Index (14 RSI): | 27.06 | Sell |
| Chaikin Money Flow: | -1631558 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (264.56 - 293.18) | Sell |
| Bollinger Bands (100): | (249.23 - 281.59) | Sell |
CURE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 114.19 | Sell |
| 20-day SMA: | 116.95 | Sell |
| 50-day SMA: | 126.36 | Sell |
| 200-day SMA: | 120.94 | Sell |
| 8-day EMA: | 111.81 | Sell |
| 20-day EMA: | 116.85 | Sell |
| 50-day EMA: | 122.59 | Sell |
| 200-day EMA: | 119.68 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 266.17 | Sell |
| 20-day SMA: | 276.01 | Sell |
| 50-day SMA: | 273.94 | Sell |
| 200-day SMA: | 209.89 | Buy |
| 8-day EMA: | 261.6 | Sell |
| 20-day EMA: | 270.55 | Sell |
| 50-day EMA: | 270.52 | Sell |
| 200-day EMA: | 230.49 | Buy |
Direxion Daily Healthcare Bull 3X ETF Earnings Growth & CURE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
Direxion Daily Healthcare Bull 3X ETF Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||